RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

Analyte monitoring device and methods of use

  • US 7,869,853 B1
  • Filed: 08/06/2010
  • Issued: 01/11/2011
  • Est. Priority Date: 04/30/1998
  • Status: Expired due to Fees
  • ×

    Create Patent Alert


    *Certain alert events are not available for your current subscription level. Upgrade
  • Save